Drug discovery and development, a risky and costly process that usually takes over a decade, is being revolutionized by three technologies – artificial intelligence (AI), organ-on-a-chip (OOC), and digital twins. AI is transforming the process from identification to compound design to predictions, demonstrating significant time and cost savings. OOC provides a more accurate alternative to animal testing by mimicking human organ functions. Lastly, the use of digital twins allows for a more patient-centric approach to clinical trials by virtually replicating patient profiles. These technologies could speed up the drug discovery process, increase success rates, and reduce costs.
Microsoft Defender Vulnerability Allows Attackers to Elevate Privileges
A newly revealed flaw in Microsoft Defender for Endpoint (CVE-2025-26684) allows local attackers to escalate privileges to SYSTEM level, gaining complete control of affected systems.
